Ignite Creation Date:
2024-05-06 @ 1:05 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03931408
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-03-03
First Post:
2019-03-29
Brief Title:
Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
Sponsor:
University of Louisville
Organization:
University of Louisville
Study Overview
Official Title:
The Evaluation of Antimicrobial Bladder Instillation on the Prevalence of Chronic Urinary Tract Infections and Bladder Dysfunction in Persons With Spinal Cord Injury
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2022-03
Last Known Status:
Active not recruiting
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Participants will undergo daily gentamicin bladder instillations to determine if its use will reduce the rate of symptomatic urinary tract infections UTIs as well as the use of oral and intravenous antibiotics in adults with chronic spinal cord injury SCI who have recurrent UTIs Participants are randomized into one of three groups 1 Gentamicin and saline instillation 2 Saline only instillation 3 Standard of care no instillation
Detailed Description:
The purpose of this study is to determine if twice daily bladder flushing with an antibiotic solution will decrease the rate of UTIs and the use of oral medications used to treat UTIs The occurrence of UTIs in the SCI population is high with a rate of about 25 episodes per year The inability to effectively empty the bladder increases the risk of UTIs which are the most common medical complication after SCI This study will help us understand the effectiveness of a local bladder therapy on preventing UTIs and improving bladder function in individuals with SCI
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None